Objectives. Laboratories that test New York State (NYS) employees and adult residents for lead exposure are required to report blood lead test results to the NYS Department of Health's Heavy Metals Registry. This registry is used to monitor exposures and to identify new high-risk occupational and nonoccupational activities.
Exposure to lead can adversely affect the nervous, hematopoietic, endocrine, renal, and reproductive systems. 1 Although the adverse health effects from lead have been recognized for centuries, adults and children in the United States continue to be exposed to lead through occupational and environmental sources. If detected early, many health problems associated with lead exposure are reversible. Regular surveillance of blood lead levels allows for the early identification of individuals at risk for poisoning, and presents an opportunity to provide interventions that can help prevent lead poisoning.
Since 1982, the New York State (NYS) Department of Health (DOH) has maintained a Heavy Metals Registry (HMR) to conduct surveillance of adult exposures to lead, arsenic, mercury, and cadmium. At the inception of the registry, laboratory reports of blood lead levels 40 micrograms/deciliter (µg/dL) in adults (aged 16 years) were required by regulation to be reported to the NYS DOH. In 1987, this reporting level was reduced to 25 µg/dL. In 1994, as part of a major childhood lead poisoning prevention initiative, legislation was enacted to require the reporting of all blood lead results for all age groups, regardless of level. Since 1994, the HMR has followed all people aged 16 years and older with blood lead levels of 10 µg/dL.
Monitoring of blood lead levels is required by the Occupational Safety and Health Administration's (OSHA's) lead standard when an employer's air sampling for lead results are elevated; 2 however, previous studies and common experience suggest that biological monitoring practices vary by size of the facility, and it is likely that many facilities have never conducted any monitoring. 3 This limits the ability of surveillance systems based on blood lead levels to identify the true magnitude of the problem. While the HMR provides only an estimate of the total burden of adult lead poisoning in NYS, it has proven to be an important tool for identifying situations in which adult lead poisoning can occur and for conducting lead poisoning prevention among adults.
This article describes the HMR data during a 13-year period. Examination of cumulative data and exposure trends allows for the development of prevention strategies aimed at populations not previously considered to be at high risk. In addition, examining reporting trends can also provide an indication of companies that have either discontinued using lead in their processes or stopped conducting biomonitoring. Because 1994 marked the enactment of the Lead in Construction Standard 4 as well as a significant change in the reporting levels to the HMR, this analysis focuses on adults reported to the HMR from 1994 through 2006.
METHODS
NYS regulations require that both in-state and outof-state laboratories report blood lead test results for specimens collected on NYS employees and residents. More than 94% of all blood lead test results received are reported electronically by the laboratories; the remaining tests are reported on paper forms.
A registry of blood lead levels can be used to identify potential sentinel occupational health events. 5 The Sentinel Health Event (occupational) model states that the occurrence of occupational disease, or a medical event such as an elevated blood lead level, serves as a warning that industrial hygiene controls may be required. The NYS DOH follows this model to address the potential for lead poisoning in the state. Adults with blood lead levels 25 µg/dL are interviewed by registry staff. Proxy interviews are conducted for those younger than 18 years of age, and those institutionalized or in prison. Demographic information is collected along with information on the subject's work and home environment. This interview is used to determine possible sources of exposure and to advise the person on appropriate control measures to limit future exposures. If an exposure is work-related, information is gathered on the employer, work location, lead protection measures in place, and whether coworkers are also potentially exposed. Information on reducing exposures is provided during interviews with the exposed individual, and brochures and relevant fact sheets are sent following an interview.
Individuals with blood lead levels between 10 µg/dL and 25 µg/dL are case matched and included in the registry, but because this group is not interviewed, much of the exposure information is often missing. Adults with blood lead levels 10 µg/dL are reported to the NYS DOH, but because of the magnitude of these reports, they are not case matched. Therefore, only information reported by the laboratory (name, address, date of birth, ethnicity, and blood lead level) is available on adults with blood lead levels 10 µg/dL. NYS DOH uses the reported blood lead levels and interview data to target specific workplaces for public health prevention and to identify potential problem industries or hobbies. 6 Sixty-five percent of those contacted for an interview have been successfully reached; for those not reached, an effort is made to obtain exposure information from the physician or laboratory. The NYS DOH industrial hygiene staff provides consulting services to worksites with employees who have high or persistently elevated blood lead levels, and to individuals engaged in hobbies with lead exposure. Recommendations to reduce lead exposure are made when problems are identified.
To test for differences in characteristics by blood lead levels, we conducted Chi-square tests. We conducted simple regression analysis to test for trends over time except when there were fewer than 10 observations over time.
RESULTS
Overall, there have been 1,178,380 blood lead test results for individuals aged 16 years or older reported to the HMR since 1994. Of these, 84% (988,708) were blood lead levels 10 µg/dL. Because of the high volume of reports received for individuals with blood lead levels 10 µg/dL, the lab reports on these people are not case matched. In general, it is assumed for this group that there is only one test per person. Supporting this, a recent analysis of a subset of the data from 2003 to 2005 indicated that females with blood lead levels 10 µg/dL had a mean of 1.1 tests (Unpublished data, NYS DOH). More than 99% of the females reported had blood lead levels 10 µg/dL, while approximately 92% of the males reported had blood lead levels 10 µg/dL. A mean of 3.7 tests were conducted per individual with blood lead levels 10 µg/dL, although those with the highest blood lead levels (60 µg/dL) had fewer tests conducted (for a mean of 2.0 tests per individual). Table 1 shows the number of adults tested each year, by blood lead level. Individuals may be tested in more than one year. There has been a substantial increase in the total number of blood lead tests reported with levels 10 µg/dL (F-value 5 187.86, p0.0001). Overall, the number of adults reported to the NYS HMR with blood lead levels 10 µg/dL has decreased (F-value 5 24.91, p50.0004), mimicking national trends. 7 This decrease was significant at all blood lead levels since 1996. The number of individuals reported with blood lead levels 25 µg/dL in NYS has declined 44%. Table 2 describes demographic characteristics including gender, age, place of residence, and source of exposure of those individuals reported since 1994, by their highest blood lead level for those with levels 10 µg/dL. Among those with blood lead levels 10 µg/dL, 80% were male. A significantly higher percentage of females had lower blood lead levels (10-24 µg/dL vs. all others, χ 2 5562.5, p0.0001). Figure 1 shows the number of males and females reported to the NYS DOH by all blood lead levels and year. The number of tests with results 10 µg/dL among males increased from 10,004 in 1994 to 28,143 in 2006 (F-value 5 61.75, p0.0001), whereas the number of tests among females with blood lead levels 10 µg/dL increased 10-fold, from 11,808 tests in 1994 to 119,997 tests in 2006 (F-value 5 201.84, p0.0001). The majority of this increase was observed among females in New York City (NYC) (data not shown). Since 1996, more than 60% of the women tested with blood lead levels 10 µg/dL were younger than 30 years of age, suggesting that more women may be receiving prenatal screening for lead. There was a significant decrease in the number of tests among males with blood lead levels 10 µg/dL (F-value 5 27.13, p50.0003), but not among females (F-value 5 2.26, p50.16).
As seen in Table 2 , slightly more than half of the adults tested with blood lead levels 10 µg/dL were between 30 and 49 years of age. A significantly higher percentage of individuals aged 16 to 29 years reported lower blood lead levels (10-24 µg/dL vs. all others, χ 2 5163.8, p0.0001). There was a significant increase in the number of adults tested each year, in each age group (data not shown). A higher percentage of adults reported to the HMR were residents of upstate New York (all of NYS excluding NYC) compared with NYC (57% vs. 32%). This is consistent with the NYS population, where approximately 57% of adults aged 18 years and older live in NYS outside of NYC. 8 The number of residents in NYC reported with blood lead levels 10 µg/dL has remained relatively stable over time, while there has been a statistically significant decrease in the number of residents in the rest of NYS reported with blood lead levels 10 µg/dL (F-value 5 54.17, p0.0001). This is consistent and statistically significant for blood lead levels of 10-24 µg/dL, 25-39 µg/dL, and 40 µg/dL ( Figure 2) .
The exposure source is identified primarily through interviews conducted with adults with blood lead levels 25 µg/dL. For 82% of the adults with blood lead levels between 10 and 24 µg/dL, source of exposure was unknown ( Table 2) . Among those with blood lead levels between 25 and 39 µg/dL, 76% had exposures only from their occupation, while 12% had only nonoccupational exposures. For adults with the highest blood lead levels (60 µg/dL), significantly more had nonoccupational exposures compared with the lower blood lead levels (χ 2 521.5, p0.0001). There has been a significant decline (F-value 5 179.24, p0.0001) over time in those with occupational exposures to lead accompanied by decreases in the number of workplaces (46%), new workers (51%), and new workplaces (62%) reported each year ( Table 3) .
The primary sources of lead for occupationally exposed individuals with elevated blood lead levels (25 µg/dL) are displayed in Table 4 . The number of individuals in the "other" category has declined over the years due to quality control efforts to better classify the source of exposure. Individuals included in this category are machine operators, assemblers, and non-construction laborers working in the manufacture of primary metals, as well as electronics and electrical equipment workers. We conducted tests for trends by source of exposure and blood lead level group; however, the number of individuals per year tested was relatively small, leading to instability in the data. Increases in the number of people reported with blood lead levels 25 µg/dL were observed among lead abaters. We observed statistically significant decreases among those with blood lead levels 40 µg/dL working with lead glass, and among those with blood lead levels between 25 and 39 µg/dL working in casting crafts or bullets, and target shooters. The number of people reported with nonoccupational exposures to lead each year has remained relatively steady, with a mean of 79 people (range: 63-106). Nonoccupational exposures represent 6% to 24% of those with blood lead levels between 25 and 59 µg/dL, and 11% to 75% of those with blood lead levels 60 µg/dL (data not shown). The primary sources of nonoccupational exposure among individuals with blood lead levels 25 µg/dL are shown in Table 5 . Individuals who have ingested lead are exposed through accidental ingestion, cookware, pica, or folk medicines. Many institutionalized people, primarily developmentally disabled, may also ingest lead. Environmental exposures often occurred outside the U.S. and were due to lead contamination of drinking water or soil, often from lead processing plants near the person's residence. Almost two-thirds of those with 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 the highest blood lead levels (40 µg/dL) were either involved in residential remodeling or were target shooters (data not shown).
DISCUSSION
Overall, there has been an increase in the number of tests being conducted on NYS residents since 1994, with more than 95% of the test results in recent years being 10 µg/dL. While increases in the number of tests have been observed among males and females, the vast majority of these tests are being conducted on females. Most of this increase has been among women of childbearing age (ages 16 to 45), suggesting that more women may be receiving prenatal screening for lead, especially within NYC. NYS has established guidelines for health-care practitioners to assist them in determining a woman's risk of lead poisoning on her initial prenatal visit. 9 If the potential for lead poisoning exists, the health-care provider is required to test the woman's blood lead level. 10 While the number of tests has increased dramatically among those with the lowest blood lead levels, there has been a decline in the prevalence of elevated blood lead levels (25 µg/dL) among adults reported to the NYS HMR, following a national trend. 7 This decrease has been observed only among those in NYS, excluding NYC, and among those with occupational exposures where there has been a 62% decrease in the number of workers with blood lead levels 25 µg/dL since 1994. While the majority of the reduction in elevated blood lead levels appears to be due to better mechanisms to control lead exposure in the workplace, other factors may also be involved. The number of NYS companies using lead has decreased as a result of either work process changes to eliminate lead or companies closing, following national trends. 11 An earlier NYS DOH survey of companies using lead in 1995 found that in 1997, approximately 7% of the companies interviewed no longer used lead, and another 7% of companies went out of business 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 Year (Unpublished data, NYS DOH). The same survey found a decrease in the number of companies conducting employee biomonitoring. In addition, between 1998 and 2005, there was an overall decline in the number of manufacturing businesses and employees in NYS, which has primarily occurred outside of NYC, helping to explain that trend. 12, 13 Another factor in the decrease of elevated blood lead levels may be the reduction or elimination of biomonitoring by some companies, although there are no data to support this. Despite the overall decline in prevalence of elevated blood lead levels reported to the HMR, occupationally d Trend analyses not conducted on fewer than 10 observations µg/dL 5 micrograms/deciliter NA 5 not applicable exposed lead abaters have shown an increase in prevalence. Nonoccupational exposures represented a relatively large percentage of the individuals with severely elevated blood lead levels (compared with lower blood lead levels). The reason for this difference is unknown; however, it is possible that these individuals are symptomatic and are therefore being tested. Although a substantial number of New York adults are having their blood lead levels tested, the HMR is unlikely to reflect the true magnitude of exposure to lead in the state. A study in California found that less than 3% of workers with direct exposure to lead were in routine blood monitoring programs. 3, 14 In NYS, there are approximately 371,000 people employed in industries with the potential for lead exposure; however, in 2006, only 389 workers were reported with blood lead results of 25 µg/dL. 12, 15 There are also numerous individuals engaged in home renovations, target shooting, and other hobbies with the potential for lead exposure who often do not get their blood lead levels tested.
CONCLUSIONS
It is accepted that a surveillance system based on blood lead levels cannot identify the true magnitude of the burden of adult lead poisoning. Despite this, the NYS HMR has proven to be an important tool for identifying situations in which adult lead poisoning is occurring and assists in guiding lead poisoning prevention among adults.
